Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Wheezing children: what is the best treatment?

10.08.2005


The treatment of a lung condition that affects almost half of all pre-school children is to be investigated by researchers at the Universities of Nottingham and Leicester.



They aim to find a definitive answer on the best way of treating the tens of thousands of children brought into hospitals every year with unexplained wheezing and shortness of breath.

The condition affecting them, known as ‘viral-induced wheezing’, is one of the commonest reasons for young children to be admitted to accident and emergency departments.


For many years, the standard treatment for this condition has been a short course of steroids — the same treatment commonly given to children suffering asthma symptoms.

But while asthma is thought to be triggered by allergies, viral-induced wheezing has different causes. And evidence has been accumulating recently that steroids may not, in fact, be the best approach for young children brought into hospital with viral-induced wheezing.

Researchers at the Universities of Nottingham and Leicester are now to investigate the treatment and establish definitively whether steroids are the best treatment or not.

Dr Jonathan Grigg and Dr Monica Lakhanpaul, both of the University of Leicester, are leading the study. Dr Grigg said: “By combining expertise at Leicester and Nottingham we will be able to recruit a large number of children into the study.

“Its results will therefore be robust enough to have an immediate impact on clinical care.”

Steroids work by reducing inflammation in the airways. But repeated doses can suppress the body’s own natural steroid production, which can have side effects on growth. So if the treatment were actually ineffective for viral-induced wheezing, such side-effects would be suffered unnecessarily.

Up to 700 children are to be enrolled onto the study from Nottingham’s City Hospital, the Queen’s Medical Centre, and Leicester Royal Infirmary over a three-year period. Half will be given steroids and half a placebo, and they will be followed up at one week after treatment and again at four weeks.

The study is being funded with a £200,000 grant from national charity Asthma UK.

Principal investigators at the University of Nottingham are Dr Alan Smyth and Professor Terence Stephenson.

Dr Smyth, senior lecturer in child health, said: “One of the commonest causes for pre-school children to be admitted to hospital is wheezing, and these children are frequently given steroids.

“Because they are effective in some similar conditions, there has been an assumption that steroids will work for viral-induced wheeze. But perhaps we haven’t been right in that assumption.

“We hope to answer an important clinical question, and provide a conclusive answer to the question of what is the best treatment to give to these children.”

Jenny Versnel, Assistant Director Research at Asthma UK said: “Asthma UK welcomes this study to address the uncertainty surrounding the efficacy of oral steroids in children where wheezing is associated with viral infections such as colds.

“It is hoped that results from this study will inform current practice.”

Dr Alan Smyth | alfa
Further information:
http://www.nottingham.ac.uk

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>